224 related articles for article (PubMed ID: 952530)
1. Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
Smith JG; Wehr RF; Chalker DK
Arch Dermatol; 1976 Aug; 112(8):1115-7. PubMed ID: 952530
[TBL] [Abstract][Full Text] [Related]
2. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
[TBL] [Abstract][Full Text] [Related]
3. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
4. Assessment of atrophy of human skin caused by corticosteroids using chamber occlusion and suction blister techniques.
Somerma S; Lassus A; Salde L
Acta Derm Venereol; 1984; 64(1):41-5. PubMed ID: 6203280
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroids.
Pace WE
Can Med Assoc J; 1973 Jan; 108(1):ll passim. PubMed ID: 4682644
[No Abstract] [Full Text] [Related]
6. Comparative evaluation of skin atrophy in man induced by topical corticoids.
Jablonska S; Groniowska M; Dabroswki J
Br J Dermatol; 1979 Feb; 100(2):193-206. PubMed ID: 154921
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical suppression by topically applied corticosteroids in healthy dogs.
Zenoble RD; Kemppainen RJ
J Am Vet Med Assoc; 1987 Sep; 191(6):685-8. PubMed ID: 2824410
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid-induced atrophy of the skin with telangiectasia. A clinical and experimental study.
Stevanović DV
Br J Dermatol; 1972 Dec; 87(6):548-56. PubMed ID: 4648801
[No Abstract] [Full Text] [Related]
9. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
Uliasz A; Zeichner J; Soung J; Wong V; Lebwohl M
Cutis; 2008 Jun; 81(6):517-9. PubMed ID: 18666395
[TBL] [Abstract][Full Text] [Related]
10. Topical corticosteroids for skin disorders.
Med Lett Drugs Ther; 1966 May; 8(10):37-8. PubMed ID: 4223426
[No Abstract] [Full Text] [Related]
11. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
12. Proceedings: Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
James MP; Black MM; Sparkes CG
Br J Dermatol; 1976 Jul; 95 Suppl 14():12. PubMed ID: 1276038
[No Abstract] [Full Text] [Related]
13. [Hypotrophic effect of topical corticosteroids on cutaneous connective tissue (author's transl)].
Weirich EG; Longauer J
Res Exp Med (Berl); 1974 Jul; 163(3):229-39. PubMed ID: 4603591
[No Abstract] [Full Text] [Related]
14. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory activity and thymolytic effect of a new corticosteroid ester (I.S.F. 2073) by topical application.
Banfi S; Cornelli U; Carpi C
Curr Ther Res Clin Exp; 1976 Jan; 19(1):126-32. PubMed ID: 812657
[No Abstract] [Full Text] [Related]
16. Comparison of synemol cream and other topical corticosteroid creams using the vasoconstrictor bioassay.
Strand LJ; Flatman CJ; Northway CS; Evans CD
Cutis; 1977 May; 19(5):689-91. PubMed ID: 862429
[TBL] [Abstract][Full Text] [Related]
17. THE USE AND ABUSE OF TOPICAL STEROID THERAPY.
WRONG NM
Can Med Assoc J; 1965 Jun; 92(25):1309-10. PubMed ID: 14291460
[No Abstract] [Full Text] [Related]
18. Double-blind clinical trial comparing fluocinonide FAPG cream with flumethasone pivalate cream.
Baran R
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):79-81. PubMed ID: 5291638
[No Abstract] [Full Text] [Related]
19. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
20. [Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
Lubach D; Hinz E
Derm Beruf Umwelt; 1986; 34(5):146-9. PubMed ID: 2947794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
